Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
Published February 10, 2016 · Recall initiated: January 11, 2016
Summary
FDA records drug Class II recall D-0649-2016, published February 10, 2016 and initiated January 11, 2016. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 116,400 bottles; Lot: Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
What to do
Voluntary: Firm initiated · Letter
Get an email if LYRICA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LYRICA
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0300711012683
- Lot
- Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc.,February 10, 2016
- FDANystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDCFebruary 10, 2016
- FDAZatarain's New Orleans Style RED BEANS AND RICE, ORIGINAL, NET WT 8 OZ, UPC 7142909849February 10, 2016
- FDAFuse 1C ColonoscopeFebruary 3, 2016
- FDAMandarin Oranges (In Light Syrup), Net Wt. 8oz (227g), Case UPC#: 100-49022-80895-6, Product UPC#:February 3, 2016
- FDATropicamide Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-585-59) and b) 15 mL BottlesFebruary 3, 2016
Questions about this recall
Was Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68 recalled?
Yes. FDA published recall D-0649-2016 on February 10, 2016. Reported hazard: FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LYRICA. UPC: 0300711012683.